Fondazione Stella Maris

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Mutation Medicine & Life Sciences
Epilepsy Medicine & Life Sciences
Genes Medicine & Life Sciences
Seizures Medicine & Life Sciences
Brain Medicine & Life Sciences
Phenotype Medicine & Life Sciences
Intellectual Disability Medicine & Life Sciences
Mitochondrial DNA Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

STELLA MARIS - DIAGNOSI E TERAPIA NEI DISTURBI PSICHIATRICI IN ETA' EVOLUTIVA

Ricerca, U.

1/1/1812/30/18

Project: Other project

STELLA MARIS - NEUROBIOLOGIA E NEUROGENETICA DEI DISTURBI DEL NEUROSVILUPPO

Ricerca, U.

1/1/1812/30/18

Project: Other project

Research Output 1974 2019

Multiple genomic copy number variants associated with periventricular nodular heterotopia indicate extreme genetic heterogeneity

Cellini, E., Vetro, A., Conti, V., Marini, C., Doccini, V., Clementella, C., Parrini, E., Giglio, S., Della Monica, M., Fichera, M., Musumeci, S. A. & Guerrini, R., Jan 1 2019, (Accepted/In press) In : European Journal of Human Genetics.

Research output: Contribution to journalArticle

Periventricular Nodular Heterotopia
Genetic Heterogeneity
Genes
Malformations of Cortical Development
Transport Vesicles

Muscle pain in mitochondrial diseases: a picture from the Italian network

Filosto, M., Cotti Piccinelli, S., Lamperti, C., Mongini, T., Servidei, S., Musumeci, O., Tonin, P., Santorelli, F. M., Simoncini, C., Primiano, G., Vercelli, L., Rubegni, A., Galvagni, A., Moggio, M., Comi, G. P., Carelli, V., Toscano, A., Padovani, A., Siciliano, G. & Mancuso, M., Jan 1 2019, In : Journal of Neurology.

Research output: Contribution to journalReview article

Mitochondrial Diseases
Myalgia
Kearns-Sayre Syndrome
Mitochondrial DNA
Mutation

Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial

Cremolini, C., Marmorino, F., Bergamo, F., Aprile, G., Salvatore, L., Masi, G., Dell'Aquila, E., Antoniotti, C., Murgioni, S., Allegrini, G., Borelli, B., Gemma, D., Casagrande, M., Granetto, C., Delfanti, S., Di Donato, S., Schirripa, M., Sensi, E., Tonini, G., Lonardi, S. & 3 othersFontanini, G., Boni, L. & Falcone, A., Mar 1 2019, In : European Journal of Cancer. 109, p. 175-182 8 p.

Research output: Contribution to journalArticle

Colorectal Neoplasms
Drug Therapy
Maintenance
Disease-Free Survival
Therapeutics